Advertisement
New Zealand markets close in 1 hour 19 minutes
  • NZX 50

    11,800.39
    -74.96 (-0.63%)
     
  • NZD/USD

    0.5925
    +0.0006 (+0.09%)
     
  • NZD/EUR

    0.5545
    +0.0003 (+0.06%)
     
  • ALL ORDS

    7,908.10
    +47.10 (+0.60%)
     
  • ASX 200

    7,652.20
    +46.60 (+0.61%)
     
  • OIL

    82.92
    +0.23 (+0.28%)
     
  • GOLD

    2,388.60
    +0.20 (+0.01%)
     
  • NASDAQ

    17,493.62
    -220.04 (-1.24%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • Dow Jones

    37,753.31
    -45.66 (-0.12%)
     
  • DAX

    17,770.02
    +3.79 (+0.02%)
     
  • Hang Seng

    16,454.17
    +202.33 (+1.24%)
     
  • NIKKEI 225

    38,090.87
    +129.07 (+0.34%)
     
  • NZD/JPY

    91.3690
    +0.0810 (+0.09%)
     

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.